English | Español

Novartis
+ Technology/Innovation
Ruth de Jauregui | Jun 7, 2017

Bristol-Myers Squibb, Novartis to study combination treatment for colorectal cancer
+ Community
Erianne Leatherman | Jun 6, 2017

Novartis highlighting cancer care data at national, international forums
+ Regulatory
Erianne Leatherman | Jun 6, 2017

Zykadia under consideration in Europe for expanded use to treat non-small cell lung cancer
+ Regulatory
Robert Hadley | Jun 3, 2017

FDA OKs Novartis' Zykadia for metastatic lung cancer affecting the brain
+ Community
Robert Hadley | May 28, 2017

Bronchodilators equal corticosteroids for COPD use, Novartis study claims 
+ Community
Ruth de Jauregui | May 21, 2017

Novartis Foundation announces new initiative on World Hypertension Day
+ Technology/Innovation
Robert Hadley | May 3, 2017

Clinical trial results offer hope for multiple sclerosis sufferers
+ Technology/Innovation
Erianne Leatherman | Apr 30, 2017

Amgen, Novartis broaden partnership for erenumab

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes